Literature DB >> 11121617

N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors.

A Martinez1, E Fernandez, A Castro, S Conde, I Rodriguez-Franco, J E Baños, A Badia.   

Abstract

A new family of 1,2,4-thiadiazolidinone derivatives containing the N-benzylpiperidine fragment has been synthesised. The acetylcholinesterase (AChE) inhibitory activity of all compounds was measured using Ellman's method and some of them turned out to be as potent as tacrine. Furthermore, compound 13 was as active as tacrine in reversing the blockade induced by tubocurarine at rat neuromuscular junction. Additionally, receptor binding studies provided new lead compounds for further development of alpha2-adrenergic and sigma-receptor antagonists. Molecular dynamic simulation using X-ray crystal structure of AChE from Torpedo californica was used to explain the possible binding mode of these new compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121617     DOI: 10.1016/s0223-5234(00)01166-1

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture.

Authors:  Shama Nasim; Monica L Guzman; Craig T Jordan; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

2.  A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Carlos Spuch; Desiree Antequera; M Isabel Fernandez-Bachiller; M Isabel Rodríguez-Franco; Eva Carro
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

Review 3.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

4.  Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.

Authors:  Ana Martinez; Carmen Gil; Daniel I Perez
Journal:  Int J Alzheimers Dis       Date:  2011-06-30

5.  A one-pot multistep cyclization yielding thiadiazoloimidazole derivatives.

Authors:  Debabrata Samanta; Anup Rana; Jan W Bats; Michael Schmittel
Journal:  Beilstein J Org Chem       Date:  2014-12-15       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.